Press release
United States Chronic Spontaneous Urticaria (CSU) Treatment Market 2025-2033: Rising Biologics and Novel Anti-Inflammatory Therapies | Sanofi S.A., Pfizer Inc., AstraZeneca
Chronic Spontaneous Urticaria (CSU) Treatment Market
This Chronic Spontaneous Urticaria (SCU) Treatment market addresses therapies for chronic hives without identifiable triggers. Rising incidence of autoimmune-related urticaria drives demand for effective treatments. Biologic drugs targeting IgE and histamine pathways are reshaping treatment protocols. Pharmaceutical R&D focuses on monoclonal antibodies and novel anti-inflammatory agents. Increasing awareness and diagnostic rates improve early intervention. The market continues to grow as biologics gain dominance in dermatological therapeutics.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Chronic Spontaneous Urticaria Treatment Market Landscape:- https://datamintelligence.com/download-sample/chronic-spontaneous-urticaria-treatment-market?rk
☛ Chronic Spontaneous Urticaria Treatment Market Recent Developments 2025:
United States:
✅ In July 2025, Horizon Therapeutics expanded access to its biologic therapy for CSU, improving symptom control and patient quality of life.
✅ In June 2025, Pfizer initiated Phase 3 trials for a new oral therapy targeting CSU patients unresponsive to antihistamines.
Japan:
✅ In August 2025, Torii Pharmaceutical launched an anti-IgE therapy for CSU, addressing growing demand in the Japanese population.
✅ In May 2025, Kyorin Pharmaceutical developed clinical protocols to integrate biologics with standard CSU care.
☛ Chronic Spontaneous Urticaria Treatment Market Trends:
This condition is treated with antihistamines, biologics, and immunomodulators. Market growth is driven by increasing prevalence, improved diagnosis, and emerging therapies.
Trends include biologics targeting IgE, personalized therapy, and guideline-based treatment optimization. North America dominates, while Europe and Asia-Pacific grow with awareness and healthcare access. Challenges include high treatment costs and chronic management.
☛ Chronic Spontaneous Urticaria Treatment Market Competitve Landscape:
Novartis AG, Genentech, Inc. (Roche Group), GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., AstraZeneca, Merck & Co., Inc., Teva Pharmaceuticals, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/chronic-spontaneous-urticaria-treatment-market
☛ Segment Covered in the Chronic Spontaneous Urticaria Treatment Market:
By Treatment Type: H2-receptor Antagonists | Leukotriene Receptor Antagonists | Omalizumab (Monoclonal Antibodies) | Corticosteroids | Others
By Route of Administration: Oral | Injectable
By Distribution Channel: Hospital Pharmacies | Retail Pharmacies | Online Pharmacies
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Chronic Spontaneous Urticaria Treatment Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=chronic-spontaneous-urticaria-treatment-market
☛ Regional Analysis for Chronic Spontaneous Urticaria Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
☛ FAQ's
Q1: What is the current size of the Chronic Spontaneous Urticaria Treatment Market and its future potential?
A: Chronic Spontaneous Urticaria (SCU) Treatment Market reached US$ 719.94 Million in 2023, with a rise of US$ 778.40 Million in 2024 and is expected to reach US1,654.42 Million by 2033.
Q2: How fast is the Chronic Spontaneous Urticaria Treatment Market expected to grow in the coming years?
A: The market is forecast to expand at a robust CAGR of 8.8% between 2025 and 2032, signaling strong global growth and investment potential.
Q3: Which regions are dominating the Chronic Spontaneous Urticaria Treatment Market and which are fastest-growing?
A: North America dominating the Chronic Spontaneous Urticaria Treatment Market.
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Chronic Spontaneous Urticaria (CSU) Treatment Market 2025-2033: Rising Biologics and Novel Anti-Inflammatory Therapies | Sanofi S.A., Pfizer Inc., AstraZeneca here
News-ID: 4210008 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Agentic AI Market to Reach US$ 98.26 Billion by 2033, Growing at 46.9% CAGR with …
The Agentic AI Market reached US$ 4.54 billion in 2025 and is expected to grow to around US$ 98.26 billion by 2033, expanding with a CAGR of approximately 46.9 % from 2026 to 2033 as enterprises increasingly adopt autonomous AI agents that can make decisions and execute complex workflows without continuous human intervention.
Growth is supported by rising demand across key applications such as enterprise workflow automation, autonomous decision‐making, intelligent virtual…
Hypersonic Weapons Market 2026 | Defense R&D Investments Surge Globally: U.S., C …
Global Hypersonic Weapons Market reached US$ 7.1 billion in 2022 and is expected to reach US$ 16.6 billion by 2031, growing with a CAGR of 11.2% during the forecast period 2024-2031.
Hypersonic weapons are advanced missile systems capable of traveling at speeds greater than Mach 5, or five times the speed of sound. These weapons combine extreme speed, maneuverability, and precision, making them challenging to detect and intercept. They are designed…
AI in Healthcare Market to Reach US$ 305.96 Billion by 2033, Growing at 30.1% CA …
The AI in Healthcare Market reached US$ 27.64 billion in 2024 and is expected to grow to around US$ 305.96 billion by 2033, expanding at a CAGR of approximately 30.1 % from 2025 to 2033 as artificial intelligence technologies become integral to healthcare operations and clinical decision‐making globally.
Growth is supported by increasing demand across key applications such as clinical diagnostics and imaging, predictive analytics for patient monitoring, drug discovery and…
United States Roofing Insulation Adhesives Market Forecast 2024-2031: High-Perfo …
Roofing Insulation Adhesives Market is valued at a significant CAGR during the forecast period (2024-2031).
Roofing Insulation Adhesives Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
